Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls.

Alzheimer's disease (AD) is the most common neurodegenerative disorder caused by neuronal loss that results in cognitive and functional impairment. Formation of neurofibrillary tangles composed of abnormal hyperphosphorylation of tau protein is one of the major pathological hallmarks of AD. Importantly, several neurodegenerative disorders, including AD, are associated with abnormal protein phosphorylation events. However, little is known thus far on global protein phosphorylation changes in AD. We report a phosphoproteomics study examining the frontal gyrus of people with AD and age-matched cognitively normal subjects, using tandem mass tag (TMT) multiplexing technology along with immobilized metal affinity chromatography to enrich phosphopeptides. We identified 4631 phosphopeptides corresponding to 1821 proteins with liquid chromatography-mass spectrometry (MS)/MS analysis on an Orbitrap Fusion Lumos Tribrid mass spectrometer. Of these, 504 phosphopeptides corresponding to 350 proteins were significantly altered in the AD brain: 389 phosphopeptides increased whereas 115 phosphopeptides decreased phosphorylation. We observed significant changes in phosphorylation of known as well as novel molecules. Using targeted parallel reaction monitoring experiments, we validated the phosphorylation of microtubule-associated protein tau and myristoylated alanine-rich protein kinase C substrate (MARCKS) in control and AD (Control = 6, AD = 11) brain samples. In conclusion, our study provides new evidence on alteration of RNA processing and splicing, neurogenesis and neuronal development, and metabotropic glutamate receptor 5 (GRM5) calcium signaling pathways in the AD brain, and it thus offers new insights to accelerate diagnostics and therapeutics innovation in AD.

[1]  Simon Youssef,et al.  Quantitative modeling of synthetic gene transfer , 2011 .

[2]  M. Albert,et al.  Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease , 2019, Proteomics. Clinical applications.

[3]  M. Albert,et al.  Phosphotyrosine profiling of human cerebrospinal fluid , 2018, Clinical Proteomics.

[4]  E. Diamandis,et al.  Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach. , 2018, Journal of proteomics.

[5]  A. Levey,et al.  Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease , 2018, Scientific Data.

[6]  Henrik Zetterberg,et al.  Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity , 2017, Nature Communications.

[7]  K. Blennow,et al.  Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer’s disease: an update , 2017, Expert review of proteomics.

[8]  A. Bartoš,et al.  Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation. , 2017, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[9]  C. Smith,et al.  Dual RNA Processing Roles of Pat1b via Cytoplasmic Lsm1-7 and Nuclear Lsm2-8 Complexes , 2017, Cell reports.

[10]  L. Petrucelli,et al.  An acetylation–phosphorylation switch that regulates tau aggregation propensity and function , 2017, The Journal of Biological Chemistry.

[11]  Timothy A. Miller,et al.  Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72‐associated amyotrophic lateral sclerosis , 2017, Annals of neurology.

[12]  Giuseppe Troiano,et al.  The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review) , 2017, International journal of molecular medicine.

[13]  Hui Zhang,et al.  MARCKS is Necessary for Oligodendrocyte Precursor Cell Maturation , 2017, Neurochemical Research.

[14]  Jian-zhi Wang 王建枝,et al.  Role of microtubule-associated protein tau phosphorylation in Alzheimer’s disease , 2017, Journal of Huazhong University of Science and Technology [Medical Sciences].

[15]  H. Kiyonari,et al.  CRMP1 and CRMP2 have synergistic but distinct roles in dendritic development , 2016, Genes to cells : devoted to molecular & cellular mechanisms.

[16]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[17]  S. Pinto,et al.  Phosphotyrosine profiling of curcumin-induced signaling , 2016, Clinical Proteomics.

[18]  Jian Cai,et al.  Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.

[19]  G. Halliday,et al.  Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease , 2015, Nature Communications.

[20]  Fabiana A. Caetano,et al.  Ca2+/Calmodulin-dependent protein Kinase II interacts with group I Metabotropic Glutamate and facilitates Receptor Endocytosis and ERK1/2 signaling: role of β-Amyloid , 2015, Molecular Brain.

[21]  S. Ackerman,et al.  Mutations in the Microtubule-Associated Protein 1A (Map1a) Gene Cause Purkinje Cell Degeneration , 2015, The Journal of Neuroscience.

[22]  A. Levey,et al.  Quantitative phosphoproteomics of Alzheimer's disease reveals cross‐talk between kinases and small heat shock proteins , 2015, Proteomics.

[23]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[24]  M. Mann,et al.  Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells , 2014, Nature Methods.

[25]  Joana M. Xavier,et al.  MicroRNA-34a Modulates Neural Stem Cell Differentiation by Regulating Expression of Synaptic and Autophagic Proteins , 2014, Molecular Neurobiology.

[26]  D. Mash,et al.  Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases , 2013, PloS one.

[27]  Chadwick M. Hales,et al.  U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease , 2013, Proceedings of the National Academy of Sciences.

[28]  Kim T. Blackwell,et al.  Molecular mechanisms underlying neuronal synaptic plasticity: systems biology meets computational neuroscience in the wilds of synaptic plasticity , 2013, Wiley interdisciplinary reviews. Systems biology and medicine.

[29]  Jenny Wong,et al.  Altered Expression of RNA Splicing Proteins in Alzheimer's Disease Patients: Evidence from Two Microarray Studies , 2013, Dementia and Geriatric Cognitive Disorders Extra.

[30]  M. Berridge.  Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia , 2013, Prion.

[31]  M. Oellerich,et al.  Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer’s disease patients , 2012, Journal of neurochemistry.

[32]  M. Gorospe,et al.  RNA-binding protein nucleolin in disease , 2012, RNA biology.

[33]  V. Berezin,et al.  NCAM2/OCAM/RNCAM: cell adhesion molecule with a role in neuronal compartmentalization. , 2012, The international journal of biochemistry & cell biology.

[34]  Akhilesh Pandey,et al.  TSLP Signaling Network Revealed by SILAC-Based Phosphoproteomics* , 2012, Molecular & Cellular Proteomics.

[35]  P. Pinton,et al.  Protein Kinases and Phosphatases in the Control of Cell Fate , 2011, Enzyme research.

[36]  A. Verkhratsky,et al.  Neurogenesis in Alzheimer’s disease , 2011, Journal of anatomy.

[37]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[38]  Kanae Iijima-Ando,et al.  Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. , 2010, Human molecular genetics.

[39]  I. Grundke‐Iqbal,et al.  Phosphorylation of Tau at Thr212, Thr231, and Ser262 Combined Causes Neurodegeneration* , 2010, The Journal of Biological Chemistry.

[40]  W. Klein,et al.  Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.

[41]  T. Pawson,et al.  Post-translational modifications in signal integration , 2010, Nature Structural &Molecular Biology.

[42]  T. Bayer,et al.  Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease , 2010, Neurobiology of Aging.

[43]  J. Trojanowski,et al.  Total and phosphorylated tau protein as biological markers of Alzheimer’s disease , 2010, Experimental Gerontology.

[44]  Akhilesh Pandey,et al.  Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. , 2009, Methods in molecular biology.

[45]  A. Verkhratsky,et al.  Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression , 2007, Journal of neurochemistry.

[46]  Mark A. Smith,et al.  Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. , 2007, Current Alzheimer research.

[47]  S. Sisodia,et al.  Presenilins and Alzheimer disease: the calcium conspiracy , 2006, Nature Neuroscience.

[48]  P. Taupin.  Neurogenesis in the adult central nervous system. , 2006, Comptes rendus biologies.

[49]  E. Masliah,et al.  Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation. , 2005, The American journal of pathology.

[50]  Lin Xie,et al.  Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Y. Yamauchi,et al.  Proteomic Analysis of Human Nop56p-associated Pre-ribosomal Ribonucleoprotein Complexes , 2003, Journal of Biological Chemistry.

[52]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[53]  S. Leurgans,et al.  Tau Conformational Changes Correspond to Impairments of Episodic Memory in Mild Cognitive Impairment and Alzheimer's Disease , 2002, Experimental Neurology.

[54]  B. Peculis,et al.  Xenopus LSm Proteins Bind U8 snoRNA via an Internal Evolutionarily Conserved Octamer Sequence , 2002, Molecular and Cellular Biology.

[55]  I. Grundke‐Iqbal,et al.  Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  T. Südhof,et al.  Synaptotagmin I functions as a calcium regulator of release probability , 2001, Nature.

[57]  Hideyuki Yamamoto,et al.  Phosphorylation of MARCKS in Alzheimer disease brains , 2000, Neuroreport.

[58]  G. Bokoch,et al.  Inhibition of myosin light chain kinase by p21-activated kinase. , 1999, Science.

[59]  D. Schomburg,et al.  Ca 2+ /calmodulin-dependent protein kinase , 1997 .

[60]  J. Ávila,et al.  Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients. , 1994, Brain research. Molecular brain research.

[61]  S. Yen,et al.  Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments , 1992, Brain Research.

[62]  P. Janmey,et al.  MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium–calmodulin , 1992, Nature.

[63]  T. Iwaki,et al.  Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[64]  L. Sternberger,et al.  Aberrant neurofilament phosphorylation in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.